echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > J Thorac Oncol: Gender differences in survival in lung cancer patients and the impact of prognostic factors on them

    J Thorac Oncol: Gender differences in survival in lung cancer patients and the impact of prognostic factors on them

    • Last Update: 2022-04-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, an Australian study was published in the Journal of Thoracic Oncology, mainly based on a large cohort study of the Australian population, to evaluate the impact of gender differences on prognosis in lung cancer patients
    .

    Recently, an Australian study was published in the Journal of Thoracic Oncology, mainly based on a large cohort study of the Australian population, to evaluate the impact of gender differences on prognosis in lung cancer patients
    .


    This is mainly based on a large cohort study in the Australian population to assess the impact of gender differences on prognosis in lung cancer patients


    The study included lung cancer patients in the 45 and Up study (2006-2009) and followed up until December 2015
    .


    The study explores prognostic factors and divides them into males and females for stratified analysis of their impact on prognosis


    The study included lung cancer patients in the 45 and Up study (2006-2009) and followed up until December 2015


    Of the 267,153 participants in the 45 and Up study, 1,130 eligible participants were diagnosed with lung cancer during follow-up (488 women and 642 men)


    The median OS of female patients was 1.


    When subgroup analyses were performed based on major prognostic factors, including histological subtype, stage at diagnosis, treatment received, and smoking status, women survived longer than men
    .


    Regardless of smoking status, women with adenocarcinoma had a better prognosis than men with adenocarcinoma (logrank p=0.


    When subgroup analyses were performed based on major prognostic factors, including histological subtype, stage at diagnosis, treatment received, and smoking status, women survived longer than men


    In univariate regression analysis, men had a significantly higher risk of lung cancer death than women (HR 1.
    43, 95% CI 1.
    25-1.
    64; p<0.
    0001)
    .


    After minimal adjustment (age and year at diagnosis), the additional risk of death was reduced by 33% (HR 1.


    In univariate regression analysis, men had a significantly higher risk of lung cancer death than women (HR 1.


    Taken together, the study shows that sex-related differences in lung cancer survival are largely determined by known prognostic factors, suggesting an opportunity to explore sex differences in treatment preference, choice, and access
    .

    Taken together, the study shows that sex-related differences in lung cancer survival are largely determined by known prognostic factors, suggesting an opportunity to explore sex differences in treatment preference, choice, and access
    .


    Taken together, our findings suggest that sex-related differences in lung cancer survival are largely determined by known prognostic factors, suggesting an opportunity to explore sex differences in treatment preference, choice, and access


    Original source:

    Original source:

    Yu XQ, Yap ML, Cheng ES, Ngo PJ, Vaneckova P, Karikios D, Canfell K, Weber MF.


    Yu XQ, Yap ML, Cheng ES, Ngo PJ, Vaneckova P, Karikios D, Canfell K, Weber MF.
    Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large Australian cohort.
    J Thorac Oncol.
    2022 Feb 3: S1556-0864(22)00085-5.
    doi: 10.
    1016/j.
    jtho.
    2022.
    01.
    016.
    Epub ahead of print.
    PMID: 35124253.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.